| Entry |
|
|---|
| Name |
Duvoglustat hydrochloride (USAN) |
|---|
| Formula |
C6H13NO4. HCl
|
|---|
| Exact mass |
199.0611
|
|---|
| Mol weight |
199.63
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01663 alpha-Glucosidase inhibitor
|
|---|
| Remark |
|
|---|
| Efficacy |
Pharmacological chaperone (alpha-glucosidase) |
|---|
| Comment |
Pharmacological chaperone
Treatment of Pompe disease
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01663 alpha-Glucosidase inhibitor
DG01280 Duvoglustat
D09606 Duvoglustat hydrochloride
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Glycosidases
GAA
D09606 Duvoglustat hydrochloride (USAN)
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01663 alpha-Glucosidase inhibitor
DG01280 Duvoglustat
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 12
1 C1y C 23.0300 -24.5000
2 C1y C 23.0300 -25.9000
3 C1y C 24.2200 -26.6000
4 C1y C 25.4800 -25.9000
5 C1x C 25.4800 -24.5000
6 N1x N 24.2200 -23.8000
7 C1b C 21.8400 -23.8000
8 O1a O 20.6500 -24.5000
9 O1a O 21.8400 -26.6000
10 O1a O 26.6700 -26.6000
11 O1a O 24.2200 -28.0000
12 X Cl 28.2100 -24.5700
BOND 11
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 1 7 1 #Up
8 7 8 1
9 2 9 1 #Down
10 4 10 1 #Down
11 3 11 1 #Up
|
|---|
